Strength and Regulation of the Different Promoters for Chromosomal β-Lactamases of Klebsiella oxytoca

Author:

Fournier Bénédicte12,Gravel Annie1,Hooper David C.2,Roy Paul H.1

Affiliation:

1. Laboratoire et Service d’Infectiologie, Centre Hospitalier de l’Université Laval, Sainte-Foy Québec, Canada,1 and

2. Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts2

Abstract

ABSTRACT The two groups of chromosomal β-lactamases from Klebsiella oxytoca (OXY-1 and OXY-2) can be overproduced 73- to 223-fold, due to point mutations in the consensus sequences of their promoters. The different versions of promoters from bla OXY-1 and bla OXY-2 were cloned upstream of the chloramphenicol acetyltransferase (CAT) gene of pKK232-8, and their relative strengths were determined in Escherichia coli and in K. oxytoca . The three different mutations in the OXY β-lactamase promoters resulted in a 4- to 31-fold increase in CAT activity compared to that of the wild-type promoter. The G→T transversion in the first base of the −10 consensus sequence caused a greater increase in the promoter strength of the wild-type promoter than the two other principal mutations (a G-to-A transition of the fifth base of the −10 consensus sequence and a T-to-A transversion of the fourth base of the −35 sequence). The strength of the promoter carrying a double mutation (transition in the Pribnow box and the transversion in the −35 hexamer) was increased 15- to 61-fold in comparison to that of the wild-type promoter. A change from 17 to 16 bp between the −35 and −10 consensus sequences resulted in a ninefold decrease of the promoter strength. The expression of the bla OXY promoter in E. coli differs from that in K. oxytoca , particularly for promoters carrying strong mutations. Furthermore, the bla OXY promoter appears not to be controlled by DNA supercoiling or an upstream curved DNA, but it is dependent on the gene copy number.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3